318 related articles for article (PubMed ID: 18603555)
1. Significance of borderline hemoglobin A2 values in an Italian population with a high prevalence of beta-thalassemia.
Giambona A; Passarello C; Vinciguerra M; Li Muli R; Teresi P; Anzà M; Ruggeri G; Renda D; Maggio A
Haematologica; 2008 Sep; 93(9):1380-4. PubMed ID: 18603555
[TBL] [Abstract][Full Text] [Related]
2. Mutational spectrum of delta-globin gene in the Portuguese population.
Morgado A; Picanço I; Gomes S; Miranda A; Coucelo M; Seuanes F; Seixas MT; Romão L; Faustino P
Eur J Haematol; 2007 Nov; 79(5):422-8. PubMed ID: 17916081
[TBL] [Abstract][Full Text] [Related]
3. [Use of capillary electrophoresis to determine hemoglobin A2 in healthy adults and alpha- and beta-thalassemia carriers].
Hua L; Li J; Liu ZY; Zhong HZ; Liao C; Xu XM
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Oct; 20(5):421-4. PubMed ID: 14556197
[TBL] [Abstract][Full Text] [Related]
4. New analytical tools and epidemiological data for the identification of HbA2 borderline subjects in the screening for beta-thalassemia.
Mosca A; Paleari R; Galanello R; Sollaino C; Perseu L; Demartis FR; Passarello C; Giambona A; Maggio A;
Bioelectrochemistry; 2008 Aug; 73(2):137-40. PubMed ID: 18486569
[TBL] [Abstract][Full Text] [Related]
5. Frequency of delta+ 27-thalassaemia in Sardinians.
Guiso L; Frogheri L; Pistidda P; Angioni L; Dore F; Pardini S; Longinotti M
Clin Lab Haematol; 1996 Dec; 18(4):241-4. PubMed ID: 9054695
[TBL] [Abstract][Full Text] [Related]
6. The clinical significance of the spectrum of interactions of CAP+1 (A-->C), a silent beta-globin gene mutation, with other beta-thalassemia mutations and globin gene modifiers in north Indians.
Garewal G; Das R; Awasthi A; Ahluwalia J; Marwaha RK
Eur J Haematol; 2007 Nov; 79(5):417-21. PubMed ID: 17900295
[TBL] [Abstract][Full Text] [Related]
7. First report on the co-inheritance of beta-globin IVS-I-5 (G-->C) thalassemia with delta globin CD12 {Asn-->Lys (AAT-->AAA)}HbA₂-NYU in Iran.
Amirian A; Karimipoor M; Jafarinejad M; Taghavi M; Kordafshari A; Fathi Azar S; Mohammadi MS; Zeinali S
Arch Iran Med; 2011 Jan; 14(1):8-11. PubMed ID: 21194254
[TBL] [Abstract][Full Text] [Related]
8. Delta-thalassemia in Cyprus.
Pavlou E; Phylactides M; Kyrri A; Kalogerou E; Makariou C; Georgiou I; Kleanthous M
Hemoglobin; 2006; 30(4):455-62. PubMed ID: 16987800
[TBL] [Abstract][Full Text] [Related]
9. Known and new delta globin gene mutations and their diagnostic significance.
Bouva MJ; Harteveld CL; van Delft P; Giordano PC
Haematologica; 2006 Jan; 91(1):129-32. PubMed ID: 16434382
[TBL] [Abstract][Full Text] [Related]
10. Masking of a β-thalassemia determinant by a novel δ-globin gene defect [Hb A2-Saurashtra or δ100(G2)Pro→Ser; HBD: c.301C>T] in Cis.
Colaco S; Trivedi A; Colah RB; Ghosh K; Nadkarni AH
Hemoglobin; 2014; 38(1):24-7. PubMed ID: 24200152
[TBL] [Abstract][Full Text] [Related]
11. Hb Lepore-Leiden: a new delta/beta rearrangement associated with a beta-thalassemia minor phenotype.
Harteveld CL; Wijermans PW; Arkesteijn SG; Van Delft P; Kerkhoffs JL; Giordano PC
Hemoglobin; 2008; 32(5):446-53. PubMed ID: 18932069
[TBL] [Abstract][Full Text] [Related]
12. Borderline hemoglobin A
Chaweephisal P; Phusua A; Fanhchaksai K; Sirichotiyakul S; Charoenkwan P
Blood Cells Mol Dis; 2019 Feb; 74():13-17. PubMed ID: 30309760
[TBL] [Abstract][Full Text] [Related]
13. Identification of a novel δ-globin gene mutation in an Iranian family.
Amirian A; Jafarinejad M; Kordafshari AR; Mosayyebzadeh M; Karimipoor M; Zeinali S
Hemoglobin; 2010; 34(6):594-8. PubMed ID: 21077769
[TBL] [Abstract][Full Text] [Related]
14. The molecular basis of normal HbA2 (type 2) beta-thalassemia in Greece.
Tzetis M; Traeger-Synodinos J; Kanavakis E; Metaxotou-Mavromati A; Kattamis C
Hematol Pathol; 1994; 8(1-2):25-34. PubMed ID: 8034555
[TBL] [Abstract][Full Text] [Related]
15. Known and new hemoglobin A2 variants in Thailand and implication for β-thalassemia screening.
Panyasai S; Fucharoen G; Fucharoen S
Clin Chim Acta; 2015 Jan; 438():226-30. PubMed ID: 25218786
[TBL] [Abstract][Full Text] [Related]
16. Molecular, hematological and clinical aspects of thalassemia major and thalassemia intermedia associated with Hb E-beta-thalassemia in Northeast Thailand.
Nuntakarn L; Fucharoen S; Fucharoen G; Sanchaisuriya K; Jetsrisuparb A; Wiangnon S
Blood Cells Mol Dis; 2009; 42(1):32-5. PubMed ID: 18951049
[TBL] [Abstract][Full Text] [Related]
17. Genotype of subjects with borderline hemoglobin A2 levels: implication for beta-thalassemia carrier screening.
Galanello R; Barella S; Ideo A; Gasperini D; Rosatelli C; Paderi L; Paglietti E; Sollaino C; Perseu L; Loi D
Am J Hematol; 1994 Jun; 46(2):79-81. PubMed ID: 8172199
[TBL] [Abstract][Full Text] [Related]
18. Molecular basis of thalassemia intermedia in Iran.
Akbari MT; Izadi P; Izadyar M; Kyriacou K; Kleanthous M
Hemoglobin; 2008; 32(5):462-70. PubMed ID: 18932071
[TBL] [Abstract][Full Text] [Related]
19. Incidence of β-thalassemia carrier on 1495 couples in preconceptional period.
Dell'Edera D; Epifania AA; Malvasi A; Pacella E; Tinelli A; Capalbo A; Lioi MB; Di Renzo G
J Matern Fetal Neonatal Med; 2013 Mar; 26(5):445-8. PubMed ID: 23039078
[TBL] [Abstract][Full Text] [Related]
20. Compromising for carrier detection of beta thalassemia based on measurement of HbA2 levels in unusual cases.
Colaco S; Colah R; Ghosh K; Nadkarni A
Clin Chim Acta; 2012 Oct; 413(19-20):1705-7. PubMed ID: 22659060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
